• Developing next generation antitumor agents
• Developing cure to treat dementia
– Stop acetylcholine esterase, prevention, cohesion and activation of beta-amyloid, prevention or treatment of dementia and improvement of cognitive abilities
– Improving learning abilities and space perception abilities of animal models with Beta-Amyloid induced dementia to that of average animal group.
– Using medicinal plants as core ingredients, the new product ensures safe treatment with least side effects especially compared with chemical drugs.
• Studying efficacy of hair growth solutions
• Studying cell signaling from antitumor agents
– Orally administrable antitumor agent with less nephrotoxicity than cisplatin
• Anti-obesity drug (STC2011-f001)
– Anti-obesity lead compound using herbal extracts
– With proven efficacy in reprogramming adipocytes into preadipocytes.
– To promote lipolysis when administered into an adipocyte with high fat concentration
STC Bio
Category:
Venture
Main Business Area
A research-centered company such as stem cell research and development, aging related p62 gene action mechanism and anti-aging product development, new drug development, energy water business and agricultural science research and development, is going to contribute to the mankind and lead the 4th industrial revolution.
Contact Details | 72 Unvillage-gil, Yongsan-gu, Seoul http://www.stcbio.com/+82-2-3438-0438enquiry@stc365.com |
---|
Find out more companies
Related products
-
Venture
Medigen Human Care
T cell immunotherapies for solid tumors, vaccine safety and natural immunity